IO Biotech Inc. (IOBT)

AI Score

Unlock

0.93

-0.01 (-1.06%)

At close: Apr 24, 2025, 3:58 PM

0.95

2.95%

After-hours: Apr 24, 2025, 06:57 PM EDT

IO Biotech Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net Income	-95.49M	-90.34M	-88M	-88.5M	-86.08M	-79.97M	-73.98M	-71.3M	-71.46M	-72.7M	-58.1M	-81.33M	-67.88M	-49.12M	-51.52M	-9.79M	-6.05M	-3.49M	-6K	-3K
Depreciation & Amortization	849K	831K	820K	793K	756K	745K	670K	494K	540K	350K	230K	220K	2.00	n/a	1K	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	4.96M	3.33M	1.65M	7.74K	8.06K	8.16K	2.41M	3.76M	5.38M	6.68M	4.76M	3.41M	1.79M	508K	41K	36.02K	32.03K	16.03K	32.00	16.00
Other Working Capital	221K	-763K	-3.49M	-1.98M	5.44M	4.93M	4.95M	5.42M	2.01M	-2.97M	-8.32M	-7.15M	-4.18M	-3.62M	2.37M	-169.95K	519.1K	648.1K	104.00	52.00
Other Non-Cash Items	6.79M	6.45M	29.76M	49.67M	46.92M	42.08M	20.4M	-497.29K	-219.28K	-2.29K	-2.63M	26.38M	26.22M	26.53M	29.14M	-148.42K	-10.84K	-17.84K	1.16K	582.00
Deferred Income Tax	n/a	-4.73M	-26.06M	-47.25M	-47.25M	-42.44M	-21.1M	87K	87K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	1M	-2.15M	-2.94M	-2.4M	5.86M	9.96M	7.53M	10.24M	4.19M	-862K	-5.47M	-6.26M	-776K	-2.41M	3.79M	755.05K	766.1K	1.33M	104.00	52.00
Operating Cash Flow	-82.35M	-85.52M	-80.7M	-81.98M	-71.74M	-61.47M	-58.83M	-53.58M	-59.73M	-66.44M	-61.21M	-57.6M	-40.65M	-24.5M	-18.55M	-9.15M	-5.26M	-2.17M	-4.7K	-2.35K
Capital Expenditures	-44K	-145K	-159K	-186K	-323K	-560K	-654K	-722K	-690K	-494K	-376K	-269K	-153K	-3	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-44K	-145K	-159K	-186K	-323K	-560K	-654K	-722K	-690K	-494K	-379K	-272K	-156K	-3K	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	-10K	71.86M	71.86M	71.86M	71.87M	n/a	n/a	n/a	103.35M	103.35M	103.35M	103.01M	-340K	-350K	-350K	-10K	-10K	-4	-2
Financial Cash Flow	n/a	-10K	71.86M	69.11M	69.11M	69.12M	-2.75M	n/a	n/a	187.54M	187.54M	187.54M	252.95M	65.41M	70.51M	70.51M	5.11M	5.11M	-4	-2
Net Cash Flow	-83.16M	-85.32M	-9.35M	-10.54M	603K	14.33M	-60.03M	-59.38M	-68.94M	105.96M	115.64M	124.95M	208.39M	39.16M	51.64M	60.11M	292.26K	3.21M	-4.74K	-2.37K
Free Cash Flow	-82.39M	-85.66M	-80.86M	-82.17M	-72.06M	-62.03M	-59.48M	-54.3M	-60.42M	-66.94M	-61.58M	-57.87M	-40.8M	-24.5M	-18.55M	-9.15M	-5.26M	-2.17M	-4.7K	-2.35K